These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12921250)

  • 1. Comparison of neural network, Bayesian, and multiple stepwise regression-based limited sampling models to estimate area under the curve.
    Ng CM
    Pharmacotherapy; 2003 Aug; 23(8):1044-51. PubMed ID: 12921250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.
    Mahmood I; Miller R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):439-45. PubMed ID: 10507242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patients.
    Peng B; Boddy AV; Cole M; Pearson AD; Chatelut E; Rubie H; Newell DR
    Eur J Cancer; 1995 Oct; 31A(11):1804-10. PubMed ID: 8541105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal sparse sampling for estimating ganciclovir/valganciclovir AUC in solid organ transplant patients using NONMEN.
    Padullés Caldés A; Colom H; Caldes A; Cerezo G; Torras J; Grinyó JM; Lloberas N
    Ther Drug Monit; 2014 Jun; 36(3):371-7. PubMed ID: 24305626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of limited sampling strategies for prediction of Ecteinascidin 743 clearance when administered as a 24-h infusion.
    van Kesteren C; Mathĵt RA; López-Lázaro L; Cvitkovic E; Taamma A; Jimeno JM; Guzman C; Schellens JH; Misset JL; Brain E; Hillebrand MJ; Rosing H; Beijnen JH
    Cancer Chemother Pharmacol; 2001 Dec; 48(6):459-66. PubMed ID: 11800026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of limited sampling designs to estimate maximal concentration and area under the curve of mizoribine in pediatric patients with renal disease.
    Ishida K; Kaneda H; Uemura O; Ushijima K; Ohta K; Goto Y; Satomura K; Shimizu M; Fujieda M; Morooka M; Yamada T; Yamada M; Wada N; Takaai M; Hashimoto Y
    Drug Metab Pharmacokinet; 2011; 26(1):71-8. PubMed ID: 20978362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the area under the concentration-versus-time curve of carboplatin following irinotecan using a limited sampling model.
    Asai G; Ando Y; Saka H; Ando M; Sugiura S; Sakai S; Hasegawa Y; Shimokata K
    Eur J Clin Pharmacol; 1998; 54(9-10):725-7. PubMed ID: 9923575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Bayesian regularized BP neural network model for analysis of aquatic ecological data-a case study of chlorophyll-a prediction in Nanzui water area of Dongting Lake.
    Xu M; Zeng GM; Xu XY; Huang GH; Sun W; Jiang XY
    J Environ Sci (China); 2005; 17(6):946-52. PubMed ID: 16465884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limited sampling approach in bioequivalence studies.
    Mahmood I; Chamberlin N; Tammara V
    Ther Drug Monit; 1997 Aug; 19(4):413-9. PubMed ID: 9263382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
    Monchaud C; Rousseau A; Leger F; David OJ; Debord J; Dantoine T; Marquet P
    Eur J Clin Pharmacol; 2003 Apr; 58(12):813-20. PubMed ID: 12698308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative computer simulation study of three different sparse-sampling methods for the estimation of steady-state area under the concentration-time curve (AUC) and maximum concentration (Cmax) in toxicokinetics.
    Mahmood I
    J Pharm Sci; 1997 May; 86(5):579-83. PubMed ID: 9145382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited sampling model for the estimation of pharmacokinetic parameters in children.
    Mahmood I
    Ther Drug Monit; 2000 Oct; 22(5):532-6. PubMed ID: 11034257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednisolone: limited sampling strategies for estimating pharmacokinetic parameters.
    Suarez-Kurtz G; Estrela Rde C; Salvadori MC
    Ther Drug Monit; 2004 Feb; 26(1):16-22. PubMed ID: 14749544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of methods for limited-sampling strategy design using data from a phase I trial of the anthrapyrazole DuP-941.
    Jodrell DI; Murray LS; Hawtof J; Graham MA; Egorin MJ
    Cancer Chemother Pharmacol; 1996; 37(4):356-62. PubMed ID: 8548882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonparametric AUC estimation in population studies with incomplete sampling: a Bayesian approach.
    Magni P; Bellazzi R; De Nicolao G; Poggesi I; Rocchetti M
    J Pharmacokinet Pharmacodyn; 2002 Dec; 29(5-6):445-71. PubMed ID: 12795241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
    Djebli N; Rousseau A; Hoizey G; Rerolle JP; Toupance O; Le Meur Y; Marquet P
    Clin Pharmacokinet; 2006; 45(11):1135-48. PubMed ID: 17048977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer.
    Yamamoto N; Tamura T; Karato A; Uenaka K; Eguchi K; Shinkai T; Ohe Y; Oshita F; Arioka H; Nakashima H
    Jpn J Cancer Res; 1994 Sep; 85(9):972-7. PubMed ID: 7961128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the prediction of extremely low birth weight neonatal mortality by regression analysis and by neural networks.
    Ambalavanan N; Carlo WA
    Early Hum Dev; 2001 Dec; 65(2):123-37. PubMed ID: 11641033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A limited sampling method for the estimation of flunarizine area under the curve (AUC) and maximum plasma concentration (Cmax).
    Mahmood I; Sahlroot JT
    Biopharm Drug Dispos; 1997 Mar; 18(2):117-26. PubMed ID: 9099448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.